Padeliporfin is a water-soluble, palladium-substituted bacteriochlorophyll photosensitizer. It is activated locally by low-power laser light in the tumor bed, forming reactive oxygen species that cause vascular-targeted necrosis of tumor tissue. It is studied in transitional cell cancer of the renal pelvis and ureter.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
WST-11
Drug type
Small molecule
Pathways
vascular-targeted photodynamic therapy, reactive oxygen species formation
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.